BREAST CANCER HORMONOTHERAPY: CURRENT STATUS OF THE PROBLEM

Tarutinov V.I., Kovaleva L.Yu.

Based on literature and own findings, the advisabilly of polyhormonytherapy in breast cancer is substantiated. Efficacy of toremiphen (Fareston) use independent from expression of estrogen receptors in a tumor, has been shown.



No comments » Add comment